CRYONIC MEDICAL

Cryonic Medical specializes in neurocryostimulation devices. These devices use carbon dioxide at -78°C to deliver precise cryoablation or controlled freezing treatments. Their applications include procedures in dermatology or soft tissue interventions where targeted cold-based therapy is required.

Cryonic Medical is based in France. The company’s headquarters and operations are located within the country, which aligns with its regulatory and manufacturing focus in the European market.

Cryonic Medical’s devices are listed in the eudamed database, which is the European Union’s central registry for medical devices. This registry ensures transparency and compliance with EU requirements for Class IIa devices.

Cryonic Medical’s devices fall under EU Class IIa classification. This classification is assigned based on the risk associated with the device’s intended use and its potential impact on patient safety, requiring compliance with specific EU Medical Device Regulations (MDR) or In Vitro Diagnostic Regulation (IVDR) requirements.